Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00903942
Recruitment Status : Withdrawn (funding was withdrawn from Drug company)
First Posted : May 19, 2009
Last Update Posted : April 27, 2015
Celgene Corporation
Information provided by:
University of Rochester

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : March 2012
  Study Completion Date : No date given